
Dr. Sanjat Chiwane
Director - Cardiology
Cardiology, Cardiac Sciences, Interventional Cardiology
Max Hospital, Gurgaon
Max Smart Super Speciality Hospital, Saket
Share Doctor Profile
Select Hospital
About Dr. Sanjat Chiwane
- Director Cardiology - Paras Hospital, Gurgaon Oct 2022- till date
- Senior Consultant Cardiologist - Artemis Health Institute, Gurgaon April 2019- Oct 2022
- Senior Consultant Cardiology - Columbia Asia Hospital, Gurgaon Oct 2014- March 2019
- Consultant Cardiologist Artemis Health Institute, Gurgaon Jan 2011- Oct 2014
- Grant Medical College and Sir.J.J.Group of Hospitals, Mumbai, 2007 - 2010
- Asst. Professor and Senior Registrar
- Super specialisation in Cardiology, (DM), Mumbai University: 2007-2010.
- M.D - Internal Medicine, Mumbai University:2004-2007
- MBBS- GMC Nagpur:1997-2003
- Complex intervention training, Asan Medical centre (ACT), Seoul 2012
- Association of Physicians of India
- Cardiological Society of India
- Faculty TCT-Asia Pacific
- Faculty ACVS India
- Faculty IIC India
- Cardiac Catheterization
- Primary and complex angioplasty (Unprotected Left Main, Bifurcation and Chronic total occlusion)
- Cardiac Pacemaker implantations
- Cardiac resynchronization therapy
- Intracoronary imaging (IVUS and OCT)
- Paediatric Cardiac Catheterizations
- Device Closure for ASD, VSD and PDA
- Echocardiography, Exercise testing and nuclear imaging.
- Antithrombotic therapy in acute coronary syndromes: What Recent trials have to say”. Published in CSI Cardiology Update 2009.
- “Percutaneous Intervention in post-MI patients”, CARDICON 2010, Patna.
- “Hypotension and Shock”. API Textbook of Medicine Vol 7. Dr. Anil Dhall and Dr. Sanjat. S.Chiwane
- Mini-crush technique in Left main coronary bifurcation: A case report. Journal of Clinical and Diagnostic research. 2022 Apr, Vol-16(4):OD 14-OD15
Research –
- DELIVER STUDY (Deliverability of the Resolute Integrity in All-Comer Vessels and Cross Over stenting)
- OPTIMIND Study: Clinical Outcomes of Patients according to pacing Modality and primary Indications.
- SIGNIFY Study: Effects of Ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double blind placebo controlled international multicenter study.
- TAO Study: A randomized double blind, triple dummy trial to compare efficacy of Otamixaban with Unfractionated Heparin with Eptifibatide, in patients with Unstable angina/Non ST segment elevation Myocardial Infarction scheduled to undergo early invasive strategy.
OPD Timings
- Wed & Fri: 12 PM to 4 PM
- Mon to Sat: 12 PM to 4 PM